Reference:
1. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var.
grubii: separate varietal status for Cryptococcus neoformans serotype A
isolates. Journal of clinical microbiology. 1999;37(3):838-40.
2. Velagapudi R, Hsueh Y-P, Geunes-Boyer S, Wright JR, Heitman J. Spores
as infectious propagules of Cryptococcus neoformans. Infection and
immunity. 2009;77(10):4345-55.
3. Cox G, Perfect J. Cryptococcus neoformans var. neoformans and gattii
and Trichosporon species. Topley and Wilson’s Microbiology and Microbial
Infections, 9th ed London: Arnold Press p. 1997:461-84.
4. Lee SC, Dickson DW, Casadevall A. Pathology of cryptococcal
meningoencephalitis: analysis of 27 patients with pathogenetic
implications. Human pathology. 1996;27(8):839-47.
5. Baker RD. The primary pulmonary lymph node complex of cryptococcosis.
American journal of clinical pathology. 1976;65(1):83-92.
6. Baker RD, Haugen RK. Tissue changes and tissue diagnosis in
cryptococcosis. A study of 26 cases. American journal of clinical
pathology. 1955;25(1).
7. Bamba S, Lortholary O, Sawadogo A, Millogo A, Guiguemde RT, Bretagne
S. Decreasing incidence of cryptococcal meningitis in West Africa in the
era of highly active antiretroviral therapy. Aids. 2012;26(8):1039-41.
8. Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. Effective treatment of
severe COVID-19 patients with tocilizumab. Proceedings of the National
Academy of Sciences. 2020;117(20):10970-5.
9. Jean SS, Fang CT, Shau WY, Chen YC, Chang SC, Hsueh PR, et al.
Cryptococcaemia: clinical features and prognostic factors. Qjm.
2002;95(8):511-8.
10. Passerini M, Terzi R, Piscaglia M, Passerini S, Piconi S.
Disseminated Cryptococcosis in a Patient With Metastatic Prostate Cancer
Who Died in the Coronavirus Disease 2019 (COVID-19) Outbreak. Cureus.
2020;12(5).